Will AAV vectors have a role in future novel gene therapy approaches?

(Mary Ann Liebert, Inc./Genetic Engineering News) Recombinant adeno-associated virus (rAAV) vectors for delivering therapeutic genes have demonstrated their safety in multiple diseases and clinical settings over the years and are a proven and effective tool that can be used to deliver new gene editing and replacement and genome modification technologies.
Source: EurekAlert! - Biology - Category: Biology Source Type: news